1. Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review;Behar;Prev. Med.,2018
2. Sunset Continue State Board of Pharmacy, SB 21-094, s 3, 12, 21. Colorado General Assembly. Accessed June 29, 2022.https://leg.colorado.gov/sites/default/files/2021a.
3. Evaluation of a pharmacist-led naloxone coprescribing program in primary care;Cariveau;J. Am. Pharm. Assoc.,2003
4. Center for Health and Environmental Data (CHED), Demont C, Yocum K, Bol K. HealthWatch No. 118; 2022. Accessed June 29, 2022. https://drive.google.com/file/d/1VGOSUU15rxV-Zj37T5c9GW13w2D76uzm/view.
5. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep 2022;71(No. RR-3):1–95.